Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

To the Editor In a recent study by Hathaway et al published in JAMA Ophthalmology, the authors showed a 4-fold increase in the risk of nonarteritic anterior ischemic optic neuropathy (NAION) with users of semaglutide among individuals with diabetes and a 7.5-fold increase in risk in the overweight cohort.

This post was originally published on this site